Solitaire With the Intention For Thrombectomy as PRIMary Endovascular Treatment (SWIFT PRIME) Trial "SWIFT PRIME"

Completed

Phase N/A Results N/A

Summary of Purpose

This study is to determine if patients experiencing an Acute Ischemic Stroke due to large vessel occlusion, treated with combined IV t-PA and Solitaire FR within 6 hours of symptom onset have less stroke-related disability than those patients treated with IV t-PA alone.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 25 February 2015.

1 Nov 2012 2 Aug 2012 1 Jan 2015 1 Jan 2015 1 Feb 2015 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available